Fenestrel Explained

Fenestrel (INN, USAN) (developmental code name ORF-3858) is a synthetic, nonsteroidal estrogen that was developed as a postcoital contraceptive in the 1960s but was never marketed.[1] [2] [3] [4] Synthesized by Ortho Pharmaceutical in 1961 and studied extensively, it was coined the "morning-after-pill" or "postcoital antifertility agent".[5] Fenestrel is a seco analogue of doisynolic acid, and a member of the cyclohexenecarboxylic acid series of estrogens.[6] [7]

See also

Notes and References

  1. Book: Elks J . The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. 14 November 2014. Springer. 978-1-4757-2085-3. 517–.
  2. Book: Milne GW . Drugs: Synonyms and Properties: Synonyms and Properties. 8 May 2018. Taylor & Francis. 978-1-351-78989-9. 1407–.
  3. Revaz C, Goldenberg B, Achtari H . [Critical study of new contraceptive methods] . fr . Schweizerische Medizinische Wochenschrift . 101 . 3 . 92–96 . January 1971 . 5544232 .
  4. Kunjappu MJ . Pioneering studies of the "morning-after" pill . The Yale Journal of Biology and Medicine . 84 . 2 . 109–111 . June 2011 . 21698041 . 3117403 .
  5. Book: Hahn DW, McGuire JL . The Use of Pharmacological Agents to Study Implantation . Glasser SR, Bullock DW . Cellular and Molecular Aspects of Implantation. https://books.google.com/books?id=iknTBwAAQBAJ&pg=PA478. 6 December 2012. Springer Science & Business Media. 978-1-4613-3180-3. 478–.
  6. Book: Kirk RE, Othmer DF . Encyclopedia of chemical technology. 1980. Wiley. 978-0-471-02065-3. 672.
  7. Book: Acta europaea fertilitatis. 1969. Piccin Medical Books..

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fenestrel".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.